Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gabardi

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Transplantation|April 11, 2012
Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantationSteven Gabardi, Peter Millen, Shelley Hurwitz, et al.
Journal of the American Society of Nephrology : JASN|April 22, 2004
Pharmacoepidemiology of anemia in kidney transplant recipientsWolfgang C Winkelmayer, Reshma Kewalramani, Mark Rutstein, et al.
Transplantation|July 27, 2011
A multicenter experience with generic tacrolimus conversionLisa M McDevitt-Potter, Basma Sadaka, Eric M Tichy, et al.
Clinical Nephrology|February 6, 2014
Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case reportKassem Safa, Merranda S Logan, Ibrahim Batal, et al.
Pharmacotherapy|October 27, 2011
Generic maintenance immunosuppression in solid organ transplant recipientsChristopher R Ensor, Jennifer Trofe-Clark, Steven Gabardi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 16, 2010
Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximabAbbie L Erickson, Keri Roberts, Sayeed K Malek, et al.
Pharmacotherapy|January 5, 2005
Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysisSteven Gabardi, Colm C Magee, Steven A Baroletti, et al.
Transplantation|August 6, 2015
A Rationale for Age-Adapted Immunosuppression in Organ TransplantationFelix Krenzien, Abdallah ElKhal, Markus Quante, et al.
The Annals of Pharmacotherapy|August 4, 2011
Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipientsSteven Gabardi, Jennifer Catella, Spencer T Martin, et al.
Reviews in Endocrine & Metabolic Disorders|July 22, 2021
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patientsJohn G Rizk, Jose G Lazo, David Quan, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Transplantation|April 11, 2012
Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantationSteven Gabardi, Peter Millen, Shelley Hurwitz, et al.
Journal of the American Society of Nephrology : JASN|April 22, 2004
Pharmacoepidemiology of anemia in kidney transplant recipientsWolfgang C Winkelmayer, Reshma Kewalramani, Mark Rutstein, et al.
Transplantation|July 27, 2011
A multicenter experience with generic tacrolimus conversionLisa M McDevitt-Potter, Basma Sadaka, Eric M Tichy, et al.
Clinical Nephrology|February 6, 2014
Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case reportKassem Safa, Merranda S Logan, Ibrahim Batal, et al.
Pharmacotherapy|October 27, 2011
Generic maintenance immunosuppression in solid organ transplant recipientsChristopher R Ensor, Jennifer Trofe-Clark, Steven Gabardi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 16, 2010
Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximabAbbie L Erickson, Keri Roberts, Sayeed K Malek, et al.
Pharmacotherapy|January 5, 2005
Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysisSteven Gabardi, Colm C Magee, Steven A Baroletti, et al.
Transplantation|August 6, 2015
A Rationale for Age-Adapted Immunosuppression in Organ TransplantationFelix Krenzien, Abdallah ElKhal, Markus Quante, et al.
The Annals of Pharmacotherapy|August 4, 2011
Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipientsSteven Gabardi, Jennifer Catella, Spencer T Martin, et al.
Reviews in Endocrine & Metabolic Disorders|July 22, 2021
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patientsJohn G Rizk, Jose G Lazo, David Quan, et al.
Pageof 7